Firma Bayer, Autor bei PR-Web

BlueRock Therapeutics, FUJIFILM Cellular Dynamics, and Opsis Therapeutics Enter into a Strategic R&D Alliance to Discover and Develop Cell Therapies for Eye Diseases

Posted on 18. May 2021 by Firma Bayer Posted in Research / Development Tagged amd, bayer, dynamics, fujifilm, imds, opsis, patients, pigmentosa, retinal, retinitis, revenues, royalty, securities, statements, with

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM Cellular Dynamics, Inc. a leading global developer and manufacturer of human induced pluripotent stem (iPS) cell technologies, and Opsis Therapeutics, LLC, a joint venture of […]